REMS
Signifor
Signifor LAR
Absorption: Unknown.
Distribution: Widely distributed, existing primarily in plasma.
Half-Life: 12 hr.
ROUTE | ONSET | PEAK | DURATION |
---|---|---|---|
SUBQ‡ | within 1 mo | 2 mo | unknown |
IM‡ | unknown | 3 mo | unknown |
‡↓in urinary free cortisol.
‡Plasma concentrations.
Contraindicated in:
Use Cautiously in:
CV: , hypertension, peripheral edema, , QT INTERVAL PROLONGATION, BRADYCARDIA, hypotension
Derm: alopecia, injection site reactions, pruritus
Endo: hyperglycemia, adrenal insufficiency, hypocortisolism, hypoglycemia, KETOACIDOSIS, pituitary hormone deficiency
F and E: hypokalemia
GI: abdominal pain, anorexia , cholelithiasis, diarrhea, nausea, ↑amylase, ↑liver enzymes, abdominal bloating, cholecystitis, constipation, fat malabsorption, steatorrhea, stool discoloration, vomiting
Hemat: ↑prothrombin time, anemia
MS: arthralgia, back pain, extremity pain, myalgia
Neuro: fatigue, headache, anxiety, dizziness, insomnia, vertigo
Drug-drug:
Cushing's Disease
Hepatic Impairment
Hepatic Impairment
Acromegaly
Hepatic Impairment
Lab Test Considerations: